来自MSN2 天
OXcan raises $11m to develop liquid biopsy tests for early cancer detection
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...
gut.bmj10 天
Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric ...
Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...
technologynetworks19 小时
40% Drop in Lung Cancer Deaths Using Biomarker Testing Trial
A study has demonstrated that biomarker testing in smokers and ex-smokers can reduce lung cancer deaths by 40%. This ...
Breast Cancer Liquid Biopsy Market to hit USD 1.9 billion by 2032, says Global Market ...
Breast cancer liquid biopsy industry is projected to witness a CAGR of 22.6% during the period 2024-2032. This growth can be ...
GlobalData on MSN5 天
Senseera secures $7.1m in funding to advance liquid biopsy platform
The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.
Lung cancer trial reveals 40% drop in deaths using biomarker testing
New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...
The American Journal of Managed Care12 天
Revolutionizing Lung Cancer Care: The Impact of Liquid Biopsies
Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, ...
The American Journal of Managed Care8 天
Combining Liquid and Tissue Biopsies for Better Lung Cancer Care
Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient concerns about technology understanding and insurance coverage, as well as ...